Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLZR:a potential 10 bagger? -- Ignore unavailable to you. Want to Upgrade?

To: Bob Davis who wrote (77)	9/23/1998 10:37:00 AM
From: Bob Davis	Read Replies (1) \| Respond to of 315

Last night's e-mailed "Overview" issue of The Napeague Letter focused on the six stocks that it follows which currently appear to be "strong and immediate investment opportunities". About CLZR it commented that "The upswing, which began in early July and gained momentum with the announcement of CLZR's quarterly results announcement on July 29th, was "blunted" by the overall downward movement of the market. As a result, the stock appears to be "plateauing" between $3.75 and $4.00. I am still waiting for the Company to file its 10-K Report with the SEC before I update its in-depth Analysis." Bob Davis The Napeague Letter napeague.com

To: Bob Davis who wrote (77)	12/23/1998 1:22:00 AM
From: DALTS	Read Replies (1) \| Respond to of 315

Bob, I havent seen your update on CLZR or any mention of it on your website even after its last news release and I was wondering if it had something to do with your personal reservations about CLZR and its future?